Bill > HF2930

This bill addresses funding and research for Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease. Specifically, the bill cancels a previous $15,000,000 appropriation and redirects those funds to create a new $15,000,000 appropriation in fiscal year 2026 for a collaborative research partnership between the University of Minnesota and the Mayo Clinic, with the goal of improving the lives of ALS patients and finding a cure. The appropriation is designated as a one-time funding and will not cancel until June 30, 2029, which provides flexibility in spending. Additionally, the bill requires the Board of Regents of the University of Minnesota to submit annual reports to the legislature from January 15, 2026, through January 15, 2030, detailing how the collaborative partnership has used the funds. The bill also repeals previous legislation related to ALS research funding, effectively replacing the prior funding mechanism with this new targeted approach focused on a specific collaborative research effort between two major Minnesota research institutions.

Education

https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF2930&ssn=0&y=2025